SciELO - Scientific Electronic Library Online

 
vol.46 número2Incremento del volumen asistencial en el Instituto Nacional de Oncología y Radiobiología entre 1992 y 2000Frecuencia, factores de riesgo e impacto en la supervivencia, de las principales causas clínicas de disfunción del injerto en el primer mes del trasplante renal índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista Cubana de Medicina

versão impressa ISSN 0034-7523versão On-line ISSN 1561-302X

Resumo

ESTEVEZ DEL TORO, Miguel H. et al. Predictive factors of response to cyclophosphamide-based induction therapy for proliferative lupus nephritis. Rev cubana med [online]. 2007, vol.46, n.2. ISSN 0034-7523.

Renal damage brings significant additional morbidity and mortality to patients with systemic erythematous lupus (SEL). Thirty eight patients with SEL and proliferative lupus nephritis were studied to determine what percentage of them has good response to intravenous cyclophosphamide-based induction therapy and the factors that allow predicting that response. These subjects were seen in the period from January 1997 to December 2006 and received induction therapy based on 6 doses of cyclophosphamide pulses every month. A longitudinal prognostic evaluation study was undertaken. Response to induction therapy was seen in 27 patients (71.1%) that was complete in 24 cases and partial in 3 patients. The analyzed variables comprising socio-demographic, clinical and histological ones, already existing before the treatment, were not significantly associated to response prediction including renal function test and renal activity, and histological chronicity indexes. It was concluded that cyclophosphamide is effective in induction therapy for proliferative lupus nephritis; however, the predictive factors for cases that will not respond to it remained unknown.

Palavras-chave : Systemic erythematosus lupus; lupus nephritis; cyclophosphamide; induction therapy; response to treatment.

        · resumo em Espanhol     · texto em Espanhol

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons